Lee, Hemin
Jin, Yinzhu
Roh, Miin
Tsacogianis, Theodore N.
Park, Sangshin
Choi, Nam-Kyong
Kim, Seoyoung C. http://orcid.org/0000-0002-2517-3579
Funding for this research was provided by:
Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital.
Article History
First Online: 6 February 2020
Compliance with Ethical Standards
:
: This study was supported by the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital.
: Seoyoung C. Kim has received research grants to the Brigham and Women’s Hospital from Pfizer, Roche, and Bristol-Myers Squibb for unrelated topics. Hemin Lee, Yinzhu Jin, Miin Roh, Theodore N. Tsacogianis, Sangshin Park, and Nam-Kyong Choi have no conflicts of interest that are directly relevant to the content of this article.
: Personal identifiers were removed from the dataset before the analysis to protect subject confidentiality. Therefore, patient informed consent was not required. The study protocol was approved by the Institutional Review Board of Brigham and Women’s Hospital.
: Not applicable.
: This work is the sole product of the authors and has been presented at the 2018 International Conference on Pharmacoepidemiology and Therapeutic Risk Management.